Globus Medical, Inc. (GMED)
$76.32+0.10%Close
BUYRECOVERY · day 7
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $10.3B
- Beta
- 0.96
- P/E (TTM)
- 19.22
- Short % float
- 6.30%
- Days to cover
- 5.1
- SI change
- +24.7%
- 1W
- -0.14%
- 1M
- +0.73%
- vs SPY 1W
- -0.01%
- vs SPY 1M
- -1.78%
Industry peers
FMP comparable companies · ranked by market cap
- SYKBUYStryker Corporation$108.3BRECOVERYQ 25$282.60-0.02%
- ZBHSELLZimmer Biomet Holdings, Inc.$17.8BRECOVERYQ 9$92.17-0.10%
- SNNSELLSmith & Nephew plc$11.6BRECOVERYQ 15$27.67+0.69%
- ATECBUYAlphatec Holdings, Inc.$1.7BRECOVERYQ -0$11.25-3.82%
- BVSSELLBioventus Inc.$917MRECOVERYQ 1$13.53+0.22%
- SIBNBUYSI-BONE, Inc.$891MBULLQ 5$20.10-2.09%
- KIDSSELLOrthoPediatrics Corp.$567MRECOVERYQ 10$22.08-0.68%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
EARNINGS HISTORY
LOADING…Loading earnings…
Company news
FAQ
- What is LOPJLB’s current signal on GMED?
- LOPJLB’s latest quantitative signal on Globus Medical, Inc. (GMED) is BUY in a RECOVERY regime. Signals are updated daily.
- What market regime is GMED in?
- Globus Medical, Inc. (GMED) is currently classified in the RECOVERY HMM market regime on LOPJLB.
- What does Globus Medical, Inc. (GMED) do?
- Globus Medical, Inc. is a global medical technology company dedicated to inventing, developing, and marketing a diverse range of healthcare solutions. Their primary focus is on addressing musculoskeletal disorders for patients worldwide. Their extensive portfolio includes a variety of spinal products. These encompass traditional fusion implants like pedicle screw and rod systems, plating system…